L.V. Prasad Eye Institute
🇮🇳India
- Country
- 🇮🇳India
- Ownership
- Private
- Established
- 1986-10-17
- Employees
- 501
- Market Cap
- -
- Website
- http://www.lvpei.org
Six-months Versus Nine-months ATT for Ocular TB
Phase 4
Completed
- Conditions
- Tuberculosis (TB)UveitisRetinal VasculitisChoroiditis
- Interventions
- Drug: Anti-Tuberculosis Treatment
- First Posted Date
- 2024-09-26
- Last Posted Date
- 2024-09-26
- Lead Sponsor
- L.V. Prasad Eye Institute
- Target Recruit Count
- 58
- Registration Number
- NCT06613919
- Locations
- 🇮🇳
LV Prasad Eye Institute, Bhubaneswar, Odisha, India
🇲🇲University of Medicine Magway, EENT Hospital, Nay Pyi Taw, Myanmar
🇹🇭Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
To Evaluate the Clinical Safety and Efficacy of Limbal Stem Cell for Treatment of Superficial Corneal Pathologies".
Early Phase 1
- Conditions
- Corneal Scars and Opacities
- Interventions
- Biological: Ex-vivo cultivated Allogeneic limbal stromal stem cells
- First Posted Date
- 2021-06-21
- Last Posted Date
- 2021-06-21
- Lead Sponsor
- L.V. Prasad Eye Institute
- Target Recruit Count
- 20
- Registration Number
- NCT04932629
CHED - Congenital Hereditary Endothelial Dystrophy: New Paradigm Shift in Therapy Using Topical Eye Drops
Phase 2
- Conditions
- Congenital Hereditary Endothelial Dystrophy of Cornea
- Interventions
- Drug: Refresh Tears 0.5% Lubricant Eye Drops
- First Posted Date
- 2021-04-14
- Last Posted Date
- 2021-04-14
- Lead Sponsor
- L.V. Prasad Eye Institute
- Target Recruit Count
- 30
- Registration Number
- NCT04843839
- Locations
- 🇮🇳
L V Prasad Eye Institute, Hyderabad, Banjara Hills, India
SEED-LVPEI Myopia Study
Not Applicable
- Conditions
- Myopia
- Interventions
- Device: SEED 1-dayPure EDOF soft contact lensDevice: Single Vision Spectacles
- First Posted Date
- 2020-11-06
- Last Posted Date
- 2021-09-24
- Lead Sponsor
- L.V. Prasad Eye Institute
- Target Recruit Count
- 108
- Registration Number
- NCT04618510
- Locations
- 🇮🇳
Pavan K. Verkicharla, Hyderabad, Telangana, India
Comparison of Different Fluence Settings for Yellow Subthreshold Laser Treatment in Diabetic Macular Edema
Completed
- Conditions
- Diabetic Retinopathy
- Interventions
- Procedure: Laser
- First Posted Date
- 2018-06-27
- Last Posted Date
- 2018-06-27
- Lead Sponsor
- L.V. Prasad Eye Institute
- Target Recruit Count
- 32
- Registration Number
- NCT03571659
Ologen® Collagen Matrix Versus Mitomycin-C in Patients With Juvenile-onset Open Angle Glaucoma
Not Applicable
Completed
- Conditions
- Open Angle Glaucoma
- Interventions
- Procedure: ologen® Collagen MatrixProcedure: Trabeculectomy with low dose mitomycin C
- First Posted Date
- 2018-06-07
- Last Posted Date
- 2023-12-12
- Lead Sponsor
- L.V. Prasad Eye Institute
- Target Recruit Count
- 30
- Registration Number
- NCT03548805
- Locations
- 🇮🇳
L V Prasad Eye Institute, Hyderabad, Telangana, India
Ologen® Collagen Matrix in Patients With Primary Congenital Glaucoma Undergoing Trabeculectomy
Not Applicable
Completed
- Conditions
- Primary Congenital GlaucomaInfantile GlaucomaDevelopmental Glaucoma
- Interventions
- Procedure: CTT with ologen® Collagen MatrixProcedure: Trab Trab
- First Posted Date
- 2018-05-30
- Last Posted Date
- 2022-04-12
- Lead Sponsor
- L.V. Prasad Eye Institute
- Target Recruit Count
- 44
- Registration Number
- NCT03541551
- Locations
- 🇮🇳
Charitha, Hyderabad, Telangana, India
Limbus-derived Stem Cells for Prevention of Postoperative Corneal Haze
Phase 1
- Conditions
- Corneal Scars and Opacities
- Interventions
- Biological: Stem cellsOther: Vehicle
- First Posted Date
- 2017-09-27
- Last Posted Date
- 2019-02-26
- Lead Sponsor
- L.V. Prasad Eye Institute
- Target Recruit Count
- 15
- Registration Number
- NCT03295292
- Locations
- 🇮🇳
LV Prasad Eye Institute, Hyderabad, Telangana, India
Combination Treatment of 5% Natamycin and 1% Voriconazole in Fungal Keratitis
Phase 2
- Conditions
- Infection, Fungal
- Interventions
- Drug: Group 1 Natamycin 5% Suspension + voriconazole 1% eye drops; Group 2 Natamycin 5% Suspension + Vehicle eye drops
- First Posted Date
- 2017-07-26
- Last Posted Date
- 2017-07-26
- Lead Sponsor
- L.V. Prasad Eye Institute
- Target Recruit Count
- 55
- Registration Number
- NCT03230058
- Locations
- 🇮🇳
GMRV Campus LV Prasad Eye Insitute, Visakhapatnam, Andhra Pradesh, India
Stem Cells Therapy for Corneal Blindness
Phase 1
- Conditions
- Corneal InjuriesCorneal BurnsCorneal Scars and Opacities
- Interventions
- Biological: Ex-vivo cultivated limbal stem cell pool
- First Posted Date
- 2016-10-28
- Last Posted Date
- 2018-03-06
- Lead Sponsor
- L.V. Prasad Eye Institute
- Target Recruit Count
- 100
- Registration Number
- NCT02948023
- Locations
- 🇮🇳
LV Prasad Eye Institute, Hyderabad, Telangana, India
© Copyright 2025. All Rights Reserved by MedPath